POTTER MYRTLE S
Director · GH, DNA
As of 2026-09-16, POTTER MYRTLE S has 40 Form 4 transactions on record across 2 companies — 7 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Pattern in the record: open-market sales filed in June in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.
Reconstructed holdings
- Direct $3.7M
- Indirect $0
| GH | direct | 20,971 sh | $3.7M |
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-22 | GH | Sale | 1,556 @ $131.16 | $204K | −6.9% of holding | 20,971 | Form 4 |
| 2025-10-17 | GH | Sale | 26 @ $66.95 | $2K | −0.1% of holding | 18,324 | Form 4 |
| 2025-09-17 | GH | Sale | 26 @ $55.63 | $1K | −0.1% of holding | 18,281 | Form 4 |
| 2025-08-19 | GH | Sale | 26 @ $59.02 | $2K | −0.1% of holding | 18,239 | Form 4 |
| 2025-07-17 | GH | Sale | 26 @ $48.20 | $1K | −0.1% of holding | 18,196 | Form 4 |
| 2025-06-18 | GH | Sale | 26 @ $49.47 | $1K | −0.1% of holding | 18,154 | Form 4 |
| 2025-06-16 | GH | Sale | 2,626 @ $49.70 | $131K | −12.6% of holding | 18,180 | Form 4 |
33 award / exercise / gift records — not counted as purchases
| Date | Company | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|
| 2026-06-17 | GH | Award / grant | 2,711 | 2,711 | Form 4 |
| 2026-06-17 | GH | Option exercise | 4,203 | 0 | Form 4 |
| 2026-06-17 | GH | Option exercise | 4,203 | 22,527 | Form 4 |
| 2025-10-15 | GH | Option exercise | 69 | 18,350 | Form 4 |
| 2025-10-15 | GH | Option exercise | 69 | 0 | Form 4 |
| 2025-09-15 | GH | Option exercise | 68 | 18,307 | Form 4 |
| 2025-09-15 | GH | Option exercise | 68 | 69 | Form 4 |
| 2025-08-15 | GH | Option exercise | 69 | 18,265 | Form 4 |
| 2025-08-15 | GH | Option exercise | 69 | 137 | Form 4 |
| 2025-07-15 | GH | Option exercise | 68 | 206 | Form 4 |
| 2025-07-15 | GH | Option exercise | 68 | 18,222 | Form 4 |
| 2025-06-18 | GH | Award / grant | 4,203 | 4,203 | Form 4 |
| 2025-06-18 | GH | Award / grant | 6,833 | 6,833 | Form 4 |
| 2025-06-15 | GH | Option exercise | 69 | 274 | Form 4 |
| 2025-06-15 | GH | Option exercise | 69 | 20,806 | Form 4 |
| 2025-06-12 | GH | Option exercise | 6,674 | 20,737 | Form 4 |
| 2025-06-12 | GH | Option exercise | 6,674 | 0 | Form 4 |
| 2025-06-11 | DNA | Option exercise | 10,822 | 0 | Form 4 |
| 2025-06-11 | DNA | Option exercise | 10,822 | 0 | Form 4 |
| 2025-06-11 | DNA | Option exercise | 10,822 | 10,822 | Form 4 |
| 2025-06-11 | DNA | Option exercise | 10,822 | 10,822 | Form 4 |
| 2025-05-15 | GH | Option exercise | 68 | 343 | Form 4 |
| 2025-05-15 | GH | Option exercise | 68 | 14,063 | Form 4 |
| 2025-04-15 | GH | Option exercise | 68 | 411 | Form 4 |
| 2025-04-15 | GH | Option exercise | 68 | 13,995 | Form 4 |
| 2025-03-15 | GH | Option exercise | 69 | 479 | Form 4 |
| 2025-03-15 | GH | Option exercise | 69 | 13,927 | Form 4 |
| 2025-02-15 | GH | Option exercise | 68 | 548 | Form 4 |
| 2025-02-15 | GH | Option exercise | 68 | 13,858 | Form 4 |
| 2025-01-15 | GH | Option exercise | 68 | 616 | Form 4 |
| 2025-01-15 | GH | Option exercise | 68 | 13,790 | Form 4 |
| 2024-12-15 | GH | Option exercise | 69 | 684 | Form 4 |
| 2024-12-15 | GH | Option exercise | 69 | 13,722 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.